These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8389737)

  • 21. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies.
    Chattopadhyay P; Starkey J; Raychaudhuri S
    J Immunol; 1991 Sep; 147(6):2055-62. PubMed ID: 1890311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
    Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
    J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
    Hombach A; Jung W; Pohl C; Renner C; Sahin U; Schmits R; Wolf J; Kapp U; Diehl V; Pfreundschuh M
    Int J Cancer; 1993 Nov; 55(5):830-6. PubMed ID: 8244580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
    Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
    Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.
    Zwicky C; Stahel RA; Jaksche H; Waibel R; Lehmann HP; Loibner H
    Br J Cancer Suppl; 1991 Jun; 14():67-70. PubMed ID: 1645576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
    Budisavljevic M; Geniteau-Legendre M; Baudouin B; Pontillon F; Verroust PJ; Ronco PM
    J Immunol; 1988 May; 140(9):3059-65. PubMed ID: 2452197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?
    Fagerberg J; Frödin JE; Wigzell H; Mellstedt H
    Cancer Immunol Immunother; 1993 Sep; 37(4):264-70. PubMed ID: 8348565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
    Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
    In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of Her-2/neu vaccine utilizing idiotypic network cascade.
    Pal S; Saha A; Mohanty K; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Cancer Biol Ther; 2007 Dec; 6(12):1916-25. PubMed ID: 18059165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
    Irvine K; Schlom J
    Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of anti-anti-idiotypic monoclonal antibody ("Ab1-like Ab3") in relation to carcinoembryonic antigen.
    Tsujisaki M; Masuya J; Okada Y; Jinnohara T; Sasaki S; Yachi A; Imai K
    J Clin Lab Anal; 2002; 16(6):279-89. PubMed ID: 12424800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen.
    Gaida FJ; Fenger U; Wagener C; Neumaier M
    Int J Cancer; 1992 May; 51(3):459-65. PubMed ID: 1592535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2.
    Sen G; Chakraborty M; Foon KA; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Nov; 3(11):1969-76. PubMed ID: 9815586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody.
    Vázquez AM; Pérez A; Hernández AM; Macías A; Alfonso M; Bombino G; Pérez R
    Hybridoma; 1998 Dec; 17(6):527-34. PubMed ID: 9890708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
    Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune events associated with protection in C57BL/6 mice immunized with anti-idiotypic antibodies mimicking protective antigens shared between gamma-irradiated cercariae vaccine and human resistance model of Schistosoma haematobium.
    Abdeen SH
    Egypt J Immunol; 2010; 17(2):105-19. PubMed ID: 23082491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
    Schnell R; Linnartz C; Katouzi AA; Schön G; Bohlen H; Horn-Lohrens O; Parwaresch RM; Lange H; Diehl V; Lemke H
    Int J Cancer; 1995 Oct; 63(2):238-44. PubMed ID: 7591211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.